Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

INTRODUCTION: Lisdexamfetamine dimesylate (LDX) is a long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Post hoc subgroup analyses were performed from two studies in children with ADHD to compare the efficacy of LDX in participants who had received pr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Jain, Rakesh, Babcock, Thomas, Burtea, Teodor, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian, Lasser, Robert, Renna, John, Duncan, Don
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Healthcare 2013
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://ncbi.nlm.nih.gov/pubmed/23681505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0027-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk